The FDA is meeting with an advisory panel about problems with children's cold medicines. Some companies have pulled products off the shelves, but that only amounts to a small fraction of the market. Jeff Tyler reports.
HCR ManorCare is deciding whether to sell the company to private-equity firm Carlyle Group. Karen Kasler reports the $6 billion deal could mean severe changes for the company's many nursing facilities.
Various groups have created their own special networking sites online. One that's popular with thousands of physicians is called Sermo. Today the site decided to let the drug maker Pfizer in on the conversation. And that's causing some indigestion. Stacey Vanek Smith reports.
A study by the website ConsumerLab.com has raised questions about a generic version of Wellbutrin, a popular antidepressant. Makers of other generics are worried the news might send consumers back to brand names. Jill Barshay reports.
Paul Krugman's new book, "The Conscience of a Liberal," considers a group determined to take over the Republican party and Franklin D. Roosevelt's New Deal. Doug Krizner discusses a gamut of issues with the author.
Studies have found over-the-counter cold medicines can have serious side effects, and there's no proof they work in young children. Big Pharma companies are pulling them off the shelves ahead of an FDA hearing.